Chemoinformaics analysis of Pueraria glycoside 2
| Molecular Weight | 548.497 | nRot | 5 |
| Heavy Atom Molecular Weight | 520.273 | nRig | 30 |
| Exact Molecular Weight | 548.153 | nRing | 5 |
| Solubility: LogS | -4.294 | nHRing | 3 |
| Solubility: LogP | -0.532 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 17 |
| nHA | 13 | APOL | 72.5162 |
| nHD | 8 | BPOL | 35.9018 |
| QED | 0.189 |
| Synth | 4.609 |
| Natural Product Likeliness | 1.856 |
| NR-PPAR-gamma | 0.51 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.986 |
| HIA | 0.911 |
| CACO-2 | -6.355 |
| MDCK | 0.0000101 |
| BBB | 0.14 |
| PPB | 0.835339 |
| VDSS | 0.614 |
| FU | 0.217439 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.025 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.223 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.006 |
| CL | 1.159 |
| T12 | 0.442 |
| hERG | 0.075 |
| Ames | 0.639 |
| ROA | 0.245 |
| SkinSen | 0.532 |
| Carcinogencity | 0.664 |
| EI | 0.015 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.865 |
| Antiviral | Yes |
| Prediction | 0.945717 |